These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31599815)

  • 21. Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
    Cohen JA; Baldassari LE; Atkins HL; Bowen JD; Bredeson C; Carpenter PA; Corboy JR; Freedman MS; Griffith LM; Lowsky R; Majhail NS; Muraro PA; Nash RA; Pasquini MC; Sarantopoulos S; Savani BN; Storek J; Sullivan KM; Georges GE
    Biol Blood Marrow Transplant; 2019 May; 25(5):845-854. PubMed ID: 30794930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT).
    Roberts F; Hobbs H; Jessop H; Bozzolini C; Burman J; Greco R; Ismail A; Kazmi M; Kirgizov K; Mancardi G; Mawson S; Muraro PA; Puyade M; Saccardi R; Withers B; Verhoeven B; Sharrack B; Snowden JA
    Front Neurol; 2020; 11():556141. PubMed ID: 33362684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist.
    Snowden JA; Sharrack B; Akil M; Kiely DG; Lobo A; Kazmi M; Muraro PA; Lindsay JO
    Clin Med (Lond); 2018 Aug; 18(4):329-334. PubMed ID: 30072560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
    Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
    Harris KM; Lu T; Lim N; Turka LA
    Front Immunol; 2018; 9():100. PubMed ID: 29456529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.
    Das J; Snowden JA; Burman J; Freedman MS; Atkins H; Bowman M; Burt RK; Saccardi R; Innocenti C; Mistry S; Laud PJ; Jessop H; Sharrack B
    Mult Scler; 2021 Jul; 27(8):1198-1204. PubMed ID: 33565902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis.
    Zhang P; Liu B
    Bone Marrow Transplant; 2020 Oct; 55(10):1928-1934. PubMed ID: 32020080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of autografting persons with multiple sclerosis are better in those not exposed to prior disease-modifying therapies.
    Sánchez-Bonilla D; Robles-Nasta M; Gallardo-Pérez MM; Hernández-Flores EJ; Montes-Robles M; Pastelín-Martínez ML; Garcés-Eisele SJ; Olivares-Gazca JC; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
    Mult Scler Relat Disord; 2023 Jul; 75():104744. PubMed ID: 37178580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status.
    Mariottini A; De Matteis E; Muraro PA
    BioDrugs; 2020 Jun; 34(3):307-325. PubMed ID: 32166703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
    Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
    Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.
    Muraro PA; Martin R; Mancardi GL; Nicholas R; Sormani MP; Saccardi R
    Nat Rev Neurol; 2017 Jul; 13(7):391-405. PubMed ID: 28621766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis.
    Bose G; Freedman MS
    J Neurol Sci; 2021 Feb; 421():117324. PubMed ID: 33497951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.
    Kasarełło K; Snarski E; Sulejczak D; Ciesielski T; Wiśniewska A; Wrzesień R; Cudnoch-Jędrzejewska A
    Arch Immunol Ther Exp (Warsz); 2021 Jun; 69(1):17. PubMed ID: 34181099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.
    Miller AE; Chitnis T; Cohen BA; Costello K; Sicotte NL; Stacom R;
    JAMA Neurol; 2021 Feb; 78(2):241-246. PubMed ID: 33104165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    Tolf A; Gauffin H; Burman J; Landtblom AM; Flensner G
    PLoS One; 2024; 19(2):e0297573. PubMed ID: 38324607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa Protocol.
    Puyade M; Brunet F; Carolina R; Fergusson N; Makedonov I; Freedman MS; Atkins H
    Curr Protoc; 2022 May; 2(5):e437. PubMed ID: 35594180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab.
    Boffa G; Lapucci C; Sbragia E; Varaldo R; Raiola AM; Currò D; Roccatagliata L; Capello E; Laroni A; Mikulska M; Gualandi F; Uccelli A; Angelucci E; Mancardi GL; Inglese M
    Eur J Neurol; 2020 Oct; 27(10):2047-2055. PubMed ID: 32418281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis.
    Ross LA; Stropp LM; Cohen JA
    Neurol Clin; 2024 Feb; 42(1):165-184. PubMed ID: 37980114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
    Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
    Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn's Disease: A Review on Behalf of ECCO and EBMT.
    Snowden JA; Panés J; Alexander T; Allez M; Ardizzone S; Dierickx D; Finke J; Hasselblatt P; Hawkey C; Kazmi M; Lindsay JO; Onida F; Salas A; Saccardi R; Vermeire S; Rovira M; Ricart E; ; ; ;
    J Crohns Colitis; 2018 Mar; 12(4):476-488. PubMed ID: 29325112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.